Dr. Katrina S. Pedersen
Claim this profileWashington University School of Medicine
About Katrina S. Pedersen
Education:
- Obtained MD from Washington University School of Medicine in 2015.
Experience:
- Completed Residency in Internal Medicine at Barnes-Jewish Hospital, Washington University School of Medicine (2015-2018).
- Undertook Fellowship in Hematology and Oncology at Washington University School of Medicine (2018-2021).
Area of expertise
Colorectal Cancer
Katrina S. Pedersen has run 9 trials for Colorectal Cancer. Some of their research focus areas include:
Rectal Cancer
Katrina S. Pedersen has run 5 trials for Rectal Cancer. Some of their research focus areas include:
Affiliated Hospitals
Washington University School Of Medicine
Siteman Cancer Center At West County Hospital
Clinical Trials Katrina S. Pedersen is currently running
Epacadostat + Chemoradiation
for Rectal Cancer
The purpose of this research study is to evaluate epacadostat when given with routine radiation therapy and chemotherapy (capecitabine and oxaliplatin) to treat rectal cancer before routine surgery is performed to remove the tumor.
Recruiting
1 award
Phase 1 & 2
CA-4948 + Chemotherapy/Immunotherapy
for Stomach & Esophageal Cancer
This is a phase I trial of CA-4948 in combination with FOLFOX/PD-1 inhibitor with or without trastuzumab for unresectable gastric, GEJ, and esophageal cancer. During the Dose Escalation portion of the study, different dose levels of CA-4948 in combination with FOLFOX/nivolumab will be evaluated by BOIN algorithm. Dose Expansion will include Cohorts A and B. Expansion Cohort A will enroll up to 12 patients with HER2 negative gastric, GEJ, and esophageal cancer at the expansion dose of CA-4948 determined during Dose Escalation and will use the same treatment regimen of FOLFOX/nivolumab. Expansion Cohort B will investigate CA-4948 at the dose determined during Dose Escalation in combination with FOLFOX/pembrolizumab and trastuzumab in up to 12 patients with HER2 positive disease; however, the initial 6 patients will be considered safety lead-in to confirm the safety and tolerability of this combination; if determined to be safe, an additional 6 patients will be enrolled for a total of 12 in Cohort B.
Recruiting
1 award
Phase 1
More about Katrina S. Pedersen
Clinical Trial Related
8 years of experience running clinical trials · Led 21 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Katrina S. Pedersen has experience with
- Fluorouracil
- Leucovorin
- Bevacizumab
- Leucovorin Calcium
- Irinotecan
- Irinotecan Hydrochloride
Breakdown of trials Katrina S. Pedersen has run
Colorectal Cancer
Rectal Cancer
Colon Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Katrina S. Pedersen specialize in?
Katrina S. Pedersen focuses on Colorectal Cancer and Rectal Cancer. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are Stage III.
Is Katrina S. Pedersen currently recruiting for clinical trials?
Yes, Katrina S. Pedersen is currently recruiting for 3 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Katrina S. Pedersen has studied deeply?
Yes, Katrina S. Pedersen has studied treatments such as Fluorouracil, Leucovorin, Bevacizumab.
What is the best way to schedule an appointment with Katrina S. Pedersen?
Apply for one of the trials that Katrina S. Pedersen is conducting.
What is the office address of Katrina S. Pedersen?
The office of Katrina S. Pedersen is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.